LON:CNSL Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis GBX 1.40 -0.05 (-3.45%) As of 05:09 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider Trades About Cambridge Nutritional Sciences Stock (LON:CNSL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CNSL alerts:Sign Up Key Stats Today's Range 1.40▼ 1.4550-Day Range 1.30▼ 1.7252-Week Range 1.26▼ 2.50Volume10,000 shsAverage Volume287,311 shsMarket Capitalization£3.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition. Read More Receive CNSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNSL Stock News HeadlinesCambridge Nutritional Sciences Reschedules AGM and Publishes 2026 Annual ReportSeptember 11, 2026 | tipranks.comCambridge Nutritional Sciences Publishes Annual Report and Sets September AGMSeptember 8, 2026 | tipranks.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 17 at 1:00 AM | Behind the Markets (Ad)Cambridge Nutritional Sciences Sets Date for 2026 Results and Investor PresentationAugust 3, 2026 | tipranks.comCambridge Nutritional Sciences Leadership Increases ShareholdingsNovember 19, 2025 | tipranks.comCambridge Nutritional Sciences Faces Historical Legal ChallengeJanuary 21, 2025 | tipranks.comCambridge Nutritional Sciences Resolves Legal Dispute with DHSCJanuary 16, 2025 | tipranks.comSee More Headlines CNSL Stock Analysis - Frequently Asked Questions How have CNSL shares performed this year? Cambridge Nutritional Sciences' stock was trading at GBX 1.94 at the beginning of 2026. Since then, CNSL shares have decreased by 28.5% and is now trading at GBX 1.39. How were Cambridge Nutritional Sciences' earnings last quarter? Cambridge Nutritional Sciences plc (LON:CNSL) issued its earnings results on Tuesday, November, 10th. The company reported GBX (0.30) earnings per share for the quarter. The firm earned £2.36 million during the quarter. Cambridge Nutritional Sciences had a negative net margin of 113.78% and a negative trailing twelve-month return on equity of 117.38%. How do I buy shares of Cambridge Nutritional Sciences? Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings11/10/2026Today11/17/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolLON:CNSL CIKN/A Webwww.cnsplc.com Phone(217) 235-3311FaxN/AEmployees3,200Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (2.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£3.03 million Net Margins-113.78% Pretax MarginN/A Return on Equity-117.38% Return on Assets-2.36% Debt Debt-to-Equity Ratio3.55 Current Ratio3.44 Quick RatioN/A Sales & Book Value Annual Sales£6.98 million Price / Sales0.48 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 4 per share Price / Book0.35Miscellaneous Outstanding Shares237,951,000Free FloatN/AMarket Cap£3.33 million OptionableN/A Beta1.91 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (LON:CNSL) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredA Nasdaq drone company just landed a deal with a Philippine billionaire's groupA Nasdaq-listed drone company just signed an exclusive agreement with Prime Strategic Holdings, part of billio...The Tomorrow Investor | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.